Stockreport

Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks [Read more]